广发纳斯达克生物科技人民币(001092)
动态评分： 5.23分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-12-31 | ERAS | Erasca Inc | 12.54 | 0.09% |
| 2021-12-31 | FGEN | FibroGen Inc | 12.5 | 0.09% |
| 2021-12-31 | RETA | Reata Pharmaceuticals Inc-A | 13.62 | 0.09% |
| 2021-12-31 | RAPT | RAPT Therapeutics Inc | 12.39 | 0.09% |
| 2021-12-31 | SGMO | Sangamo Therapeutics Inc | 12.76 | 0.09% |
| 2021-12-31 | LYEL | Lyell Immunopharma Inc | 12.35 | 0.09% |
| 2021-12-31 | RVNC | Revance Therapeutics Inc | 13.67 | 0.09% |
| 2021-12-31 | INVA | Innoviva Inc | 12.36 | 0.09% |
| 2021-12-31 | RNA | Avidity Biosciences Inc | 11.32 | 0.08% |
| 2021-12-31 | MNKD | 曼恩凯德生物医疗 | 11.29 | 0.08% |
| 2021-12-31 | MORF | Morphic Holding Inc | 11.63 | 0.08% |
| 2021-12-31 | SNDX | Syndax Pharmaceuticals Inc | 11.43 | 0.08% |
| 2021-12-31 | AMPH | Amphastar Pharmaceuticals Inc | 11.79 | 0.08% |
| 2021-12-31 | SRRK | Scholar Rock Holding Corp | 11.13 | 0.08% |
| 2021-12-31 | CHRS | Coherus BioSciences Inc | 12.07 | 0.08% |
| 2021-12-31 | KURA | Kura Oncology Inc | 11.6 | 0.08% |
| 2021-12-31 | ALXO | ALX Oncology Holdings Inc | 11.25 | 0.08% |
| 2021-12-31 | INBX | Inhibrx Inc | 11 | 0.08% |
| 2021-12-31 | VERV | Verve Therapeutics Inc | 11.78 | 0.08% |
| 2021-12-31 | ZGNX | Zogenix Inc | 12.01 | 0.08% |
公告&资料